Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting
PaperCitations, authors & open-access status
Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 57 citations, 2018 year and hybrid oa status.
57
Citations
2018
Year
hybrid
OA Status